Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
34
VYCO Quote, Financials, Valuation and Earnings
Last price:
$0.16
Seasonality move
:
-4.65%
Day range:
$0.16 - $0.16
52-week range:
$0.04 - $0.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.87x
P/B ratio:
--
Volume:
100
Avg. volume:
13K
1-year change:
125.14%
Market cap:
$5.3M
Revenue:
$1.6M
EPS (TTM):
-$0.01
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Vycor Medical, Inc. has -- downside to fair value with a price target of -- per share.
VYCO vs. S&P 500
-
Over the past 5 trading days, Vycor Medical, Inc. has underperformed the S&P 500 by -3% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Vycor Medical, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Vycor Medical, Inc. has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Vycor Medical, Inc. reported revenues of $513.8K.
Earnings Growth
-
Vycor Medical, Inc. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Vycor Medical, Inc. reported earnings per share of -$0.00.
Enterprise value:
6.2M
EV / Invested capital:
--
Price / LTM sales:
2.87x
EV / EBIT:
69.31x
EV / Revenue:
3.27x
PEG ratio (5yr expected):
-0.46x
EV / Free cash flow:
-65.93x
Price / Operating cash flow:
116.17x
Enterprise value / EBITDA:
40.49x
Gross Profit (TTM):
$1.6M
Return On Assets:
-1.5%
Net Income Margin (TTM):
-0.76%
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
6.25%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.4M | $1.4M | $1.9M | $390.9K | $513.8K | |
| Gross Profit | $1.2M | $1.2M | $1.6M | $339.2K | $437.1K | |
| Operating Income | $13.1K | -$92.5K | $89.8K | -$35.1K | $32.1K | |
| EBITDA | $74K | -$30.4K | $153.6K | -$19.4K | $48K | |
| Diluted EPS | -$0.01 | -$0.02 | -$0.01 | -$0.01 | -$0.00 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $562.2K | $579.8K | $625.9K | $743.4K | $662.6K | |
| Total Assets | $1M | $949.8K | $1.1M | $1.1M | $941.2K | |
| Current Liabilities | $3.1M | $3.6M | $4M | $4.6M | $4.8M | |
| Total Liabilities | $3.3M | $3.8M | $4.3M | $4.8M | $5M | |
| Total Equity | -$2.3M | -$2.8M | -$3.2M | -$3.7M | -$4M | |
| Total Debt | $898.5K | $147.1K | $255.7K | $205.1K | $150.3K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$9.4K | $103.9K | -$91K | $10.5K | -$72.4K | |
| Cash From Investing | -$3.2K | -$10.3K | -$2.6K | -$5K | -- | |
| Cash From Financing | $49.1K | -$5K | $200 | $32.9K | $37K | |
| Free Cash Flow | -$12.7K | $93.6K | -$94.4K | $6.1K | -$72.4K | |
VYCO
Sector
Market Cap
$5.3M
$28.2M
Price % of 52-Week High
31.48%
51.2%
Dividend Yield
0%
0%
Shareholder Yield
0.09%
-1.54%
1-Year Price Total Return
125.14%
-18.1%
Beta (5-Year)
-0.389
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.16
200-day SMA
Buy
Level
$0.13
Bollinger Bands (100)
Sell
Level
0.14 - 0.18
Chaikin Money Flow
Buy
Level
30.6K
20-day SMA
Sell
Level
$0.17
Relative Strength Index (RSI14)
Sell
Level
42.22
ADX Line
Sell
Level
12.61
Williams %R
Neutral
Level
-31
50-day SMA
Sell
Level
$0.17
MACD (12, 26)
Buy
Level
0.04
25-day Aroon Oscillator
Sell
Level
-24
On Balance Volume
Neutral
Level
19.3K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-49.3504)
Sell
CA Score
(Annual)
Level (-18.3573)
Buy
Beneish M-Score
(Annual)
Level (-4.7222)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (34.7762)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (9)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Vycor Medical, Inc. engages in the provision of innovative surgical and therapeutic solutions to the medical community. It operates through the Vycor Medical and NovaVision segments. The Vycor Medical segment focuses on devices for neurosurgery. The NovaVision segment offers neuro stimulation therapies and diagnostic devices for the treatment and screening of vision field loss. The company was founded by Heather N. Vinas and Heather N. Jensen on June 17, 2005 and is headquartered in Boca Raton, FL.
Stock Forecast FAQ
In the current month, VYCO has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The VYCO average analyst price target in the past 3 months is --.
-
Where Will Vycor Medical, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Vycor Medical, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Vycor Medical, Inc.?
Analysts are divided on their view about Vycor Medical, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Vycor Medical, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Vycor Medical, Inc.'s Price Target?
The price target for Vycor Medical, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is VYCO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Vycor Medical, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of VYCO?
You can purchase shares of Vycor Medical, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Vycor Medical, Inc. shares.
-
What Is The Vycor Medical, Inc. Share Price Today?
Vycor Medical, Inc. was last trading at $0.16 per share. This represents the most recent stock quote for Vycor Medical, Inc.. Yesterday, Vycor Medical, Inc. closed at $0.16 per share.
-
How To Buy Vycor Medical, Inc. Stock Online?
In order to purchase Vycor Medical, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get VYCO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VYCO
Sector
P/E ratio
--
23.92x
PEG ratio
-0.46x
-0.01x
P/B ratio
--
1.83x
Price / LTM sales
2.87x
1.61x
Growth Metrics
VYCO
Sector
Revenue growth
31.45%
4.6%
Earnings growth
30.88%
10.88%
Revenue (5-year growth)
2.67%
6.46%
Earnings forecast
--
-$0.21
Profitability
VYCO
Sector
Profitability FY 2024
$1.4M
$3.5M
Return on invested capital
--
-31.84%
Return on assets
-1.5%
-27.96%
Return on equity
--
-37.63%
Earnings Date
Last Earnings Date
Dec
28
Next Earnings Date
Dec
28
Estimated Next Earnings Date
Mar
29
Balance Sheet
VYCO
Sector
Total cash
$64.2K
$26.3M
Short term investments
--
$25.7M
Total assets
$998.1K
$76.9M
Long term debt
$150.3K
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
